India Exchange Filings

Q2 FY27 Earnings and Business Update

Viyash Scientific Ltd reports Q2 FY27 revenue of ₹987.9 crore, up 16.2% year on year

  • EBITDA before ESOP cost was ₹207.7 crore, up 10.3% year on year; margin was 21.0%, down 110 bps.
  • Net profit rose 16.1% year on year to ₹84.7 crore; ESOP expense was ₹42.1 crore and exceptional items were nil.
  • Completed the BioForLife acquisition in Italy and outlined investments in oncology R&D, companion-animal manufacturing and API capacity.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.